Paraneoplastic syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(38 intermediate revisions by the same user not shown)
Line 2: Line 2:
'''For patient information, click [[Paraneoplastic syndrome (patient information)|here]]'''
'''For patient information, click [[Paraneoplastic syndrome (patient information)|here]]'''
{{Paraneoplastic syndrome}}
{{Paraneoplastic syndrome}}
{{CMG}} ; {{AE}} {{G.D.}}<br>
{{SK}} Paraneoplastic syndrome
==Overview==
'''Paraneoplastic syndromes''' are a rare type of [[diseases|disease]] that is caused by abnormal [[immune]] systems resulting from [[cancerous]] cells. Paraneoplastic syndromes are [[disorders]] due to the release of [[hormones]], or peptides that cause [[immune]] cross-reactivity between [[cancerous]] [[cells]] and normal [[tissues]]. Sometimes the [[symptoms]] of paraneoplastic syndromes show even before the [[diagnosis]] of a [[Malignant|malignancy]]. There is no [[screening]] for paraneoplastic syndromes. The stage and type of [[diagnosis]] of [[cancer]] determine the [[prognosis]] of a paraneoplastic syndrome. The [[causes]] are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as [[musculocutaneous]], [[neurological]], [[hematological]] and [[Endocrine|endocrines]]. They are no cures for the paraneoplastic syndrome, but [[cancer]] treatment and some [[medications]] to reduce [[Autoimmunity|autoimmune]] responses are helpful.
==Classification==
* Paraneoplastic syndromes may be [[Classification|classified]] into 5 main categories accordingly:
{| class="wikitable"
|+
|-
| align="center" style="background:#4479BA; color: #FFFFFF;" |'''Type of paraneoplastic syndrome'''
| align="center" style="background:#4479BA; color: #FFFFFF;" |'''Subtype'''
| align="center" style="background:#4479BA; color: #FFFFFF;" |'''Associated Cancers'''
|-
| rowspan="5"  align="center" style="background:#f0f0f0;" |[[Endocrine]]
|
* [[Hypercalcemia]]<ref name="Stewart2005">{{cite journal|last1=Stewart|first1=Andrew F.|title=Hypercalcemia Associated with Cancer|journal=New England Journal of Medicine|volume=352|issue=4|year=2005|pages=373–379|issn=0028-4793|doi=10.1056/NEJMcp042806}}</ref>
|
* [[Breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])[[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
*
|-
|
* [[Syndrome of inappropriate antidiuretic hormone|SIADH]]<ref name="Raftopoulos2007">{{cite journal|last1=Raftopoulos|first1=Harry|title=Diagnosis and management of hyponatremia in cancer patients|journal=Supportive Care in Cancer|volume=15|issue=12|year=2007|pages=1341–1347|issn=0941-4355|doi=10.1007/s00520-007-0309-9}}</ref>
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
*
|-
|
* [[Ectopic]] [[ACTH]] [[secretion]]<ref name="BarbosaRodien2005">{{cite journal|last1=Barbosa|first1=Sandrine Laboureau-Soares|last2=Rodien|first2=Patrice|last3=Leboulleux|first3=Sophie|last4=Niccoli-Sire|first4=Patricia|last5=Kraimps|first5=Jean-Louis|last6=Caron|first6=Philippe|last7=Archambeaud-Mouveroux|first7=Françoise|last8=Conte-Devolx|first8=Bernard|last9=Rohmer|first9=Vincent|title=Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature|journal=Thyroid|volume=15|issue=6|year=2005|pages=618–623|issn=1050-7256|doi=10.1089/thy.2005.15.618}}</ref>
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]], [[medullary carcinoma of the thyroid]] and other [[Cancer|cancers]]
|-
|
* [[Tumor induced osteomalacia]]<ref name="FlorenzanoGafni2017">{{cite journal|last1=Florenzano|first1=Pablo|last2=Gafni|first2=Rachel I.|last3=Collins|first3=Michael T.|title=Tumor-induced osteomalacia|journal=Bone Reports|volume=7|year=2017|pages=90–97|issn=23521872|doi=10.1016/j.bonr.2017.09.002}}</ref>
|
* [[Metastatic]] [[breast cancer]]
*
|-
|
* [[Hypoglycemia]]<ref name="NauckReinecke2007">{{cite journal|last1=Nauck|first1=Michael A.|last2=Reinecke|first2=Manfred|last3=Perren|first3=Aurel|last4=Frystyk|first4=Jan|last5=Berishvili|first5=Giorgi|last6=Zwimpfer|first6=Cornelia|last7=Figge|first7=Anja M.|last8=Flyvbjerg|first8=Allan|last9=Lankisch|first9=Paul G.|last10=Blum|first10=Werner F.|last11=Klöppel|first11=Günter|last12=Schmiegel|first12=Wolff|last13=Zapf|first13=Jürgen|title=Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I in a Patient with Metastasizing Large-Cell Carcinoma of the Lung|journal=The Journal of Clinical Endocrinology & Metabolism|volume=92|issue=5|year=2007|pages=1600–1605|issn=0021-972X|doi=10.1210/jc.2006-2573}}</ref>
|
* [[Gastrointestinal tract|GI]] cancers, [[mesothelioma]], [[lung]], [[real cancer]], and [[sarcomas]]
|-
| rowspan="6"  align="center" style="background:#f0f0f0;" |[[Mucocutaneous|Musculocutaneous]]
|
* [[Dermatomyositis]]<ref name="ThiersSahn2009">{{cite journal|last1=Thiers|first1=B. H.|last2=Sahn|first2=R. E.|last3=Callen|first3=J. P.|title=Cutaneous Manifestations of Internal Malignancy|journal=CA: A Cancer Journal for Clinicians|volume=59|issue=2|year=2009|pages=73–98|issn=0007-9235|doi=10.3322/caac.20005}}</ref>
|
* [[Breast cancer|Breast]], [[Ovarian cancer|ovarian]], [[Lung cancer|lung]], and [[prostate cancer]]
*
|-
|
* [[Leser-Trelat sign|Leser-Trélat sign]]<ref name="GaduputiChandrala2014">{{cite journal|last1=Gaduputi|first1=Vinaya|last2=Chandrala|first2=Chaitanya|last3=Tariq|first3=Hassan|last4=Kanneganti|first4=Kalyan|title=Sign of Leser-Trélat Associated with Esophageal Squamous Cell Cancer|journal=Case Reports in Oncological Medicine|volume=2014|year=2014|pages=1–3|issn=2090-6706|doi=10.1155/2014/825929}}</ref>
|
* Gastrointestinal [[adenocarcinomas]] ([[Gastric adenocarcinoma|gastric]], [[Colon adenocarcinoma|colon]], rectal), [[breast cancer]], [[lymphoproliferative disorders]]/[[lymphoma]], and [[melanoma]].
*
|-
|
* [[Acanthosis nigricans]]<ref name="ThiersSahn2009">{{cite journal|last1=Thiers|first1=B. H.|last2=Sahn|first2=R. E.|last3=Callen|first3=J. P.|title=Cutaneous Manifestations of Internal Malignancy|journal=CA: A Cancer Journal for Clinicians|volume=59|issue=2|year=2009|pages=73–98|issn=0007-9235|doi=10.3322/caac.20005}}</ref>
|
* [[Gastric adenocarcinoma]], [[endometrial cancer]].
*
|-
|
* [[Necrolytic migratory erythema]]<ref name="TremblayMarcil2017">{{cite journal|last1=Tremblay|first1=Catherine|last2=Marcil|first2=Isabelle|title=Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition|journal=Journal of Cutaneous Medicine and Surgery|volume=21|issue=6|year=2017|pages=559–561|issn=1203-4754|doi=10.1177/1203475417719051}}</ref>
|
* [[Glucagonoma]]
*
|-
|
* [[Sweet's syndrome]]<ref name="CohenKurzrock1987">{{cite journal|last1=Cohen|first1=Philip R.|last2=Kurzrock|first2=Razelle|title=Sweet's syndrome and malignancy|journal=The American Journal of Medicine|volume=82|issue=6|year=1987|pages=1220–1226|issn=00029343|doi=10.1016/0002-9343(87)90229-4}}</ref>
|
* [[Acute myeloid leukemia|Acute myelogenous leukemia]], [[Myeloproliferative disease|myeloproliferative disorders]], [[lymphoproliferative disorders]], [[myelodysplastic syndrome]], and [[carcinoma]]
*
|-
|
* [[Pyoderma gangrenosum]]<ref name="YouJu2018">{{cite journal|last1=You|first1=Hye Rin|last2=Ju|first2=Jae-Kyun|last3=Yun|first3=Sook Jung|last4=Lee|first4=Jee-Bum|last5=Kim|first5=Seong-Jin|last6=Won|first6=Young Ho|last7=Lee|first7=Seung-Chul|title=Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma|journal=Annals of Dermatology|volume=30|issue=1|year=2018|pages=79|issn=1013-9087|doi=10.5021/ad.2018.30.1.79}}</ref>
|
* [[Rectal Adenocarcinoma]], [[myeloproliferative disorders]], [[colon cancer]]


{{CMG}} ; {{AE}} {{G.D.}}
*
|-
|+
|-
| rowspan="11"  align="center" style="background:#f0f0f0;" |[[Neurological]]<ref name="PelosofGerber2010">{{cite journal|last1=Pelosof|first1=Lorraine C.|last2=Gerber|first2=David E.|title=Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment|journal=Mayo Clinic Proceedings|volume=85|issue=9|year=2010|pages=838–854|issn=00256196|doi=10.4065/mcp.2010.0099}}</ref>
|
* [[Paraneoplastic cerebellar degeneration]]<ref name="AbdulazizYu2018">{{cite journal|last1=Abdulaziz|first1=Ammar Taha Abdullah|last2=Yu|first2=Xiao Qing|last3=Zhang|first3=Le|last4=Jiang|first4=Xin Yue|last5=Zhou|first5=Dong|last6=Li|first6=Jin Mei|title=Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism|journal=Medicine|volume=97|issue=24|year=2018|pages=e10717|issn=0025-7974|doi=10.1097/MD.0000000000010717}}</ref>


{{SK}} Paraneoplastic syndrome
|
* [[Breast cancer|Breast]] and [[gynecological malignancies]]
 
*
|-
|
* [[Encephalomyelitis]]<ref name="Graus2001">{{cite journal|last1=Graus|first1=F.|title=Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients|journal=Brain|volume=124|issue=6|year=2001|pages=1138–1148|issn=14602156|doi=10.1093/brain/124.6.1138}}</ref>
 
|
* [[Bronchial cancer]] (typically [[small cell lung carcinoma]])
*
|-
|
* [[Limbic encephalitis]]<ref name="ShenXu2018">{{cite journal|last1=Shen|first1=Kaini|last2=Xu|first2=Yan|last3=Guan|first3=Hongzhi|last4=Zhong|first4=Wei|last5=Chen|first5=Minjiang|last6=Zhao|first6=Jing|last7=Li|first7=Longyun|last8=Wang|first8=Mengzhao|title=Paraneoplastic limbic encephalitis associated with lung cancer|journal=Scientific Reports|volume=8|issue=1|year=2018|issn=2045-2322|doi=10.1038/s41598-018-25294-y}}</ref>
|
* [[Lung cancer]]
*
|-
|
* [[Encephalitis|Brainstem encephalitis]]<ref name="Blaes2013">{{cite journal|last1=Blaes|first1=Franz|title=Paraneoplastic Brain Stem Encephalitis|journal=Current Treatment Options in Neurology|volume=15|issue=2|year=2013|pages=201–209|issn=1092-8480|doi=10.1007/s11940-013-0221-1}}</ref><ref name="PelosofGerber2010">{{cite journal|last1=Pelosof|first1=Lorraine C.|last2=Gerber|first2=David E.|title=Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment|journal=Mayo Clinic Proceedings|volume=85|issue=9|year=2010|pages=838–854|issn=00256196|doi=10.4065/mcp.2010.0099}}</ref>
|
* [[Lung cancer]], [[testicular cancer]], [[neuroendocrine]] [[tumors]]
 
*
|-
|
* [[Opsoclonus]] (involving eye movement)<ref name="Blaes2013">{{cite journal|last1=Blaes|first1=Franz|title=Paraneoplastic Brain Stem Encephalitis|journal=Current Treatment Options in Neurology|volume=15|issue=2|year=2013|pages=201–209|issn=1092-8480|doi=10.1007/s11940-013-0221-1}}</ref>
|
* [[Neuroblastoma]], [[small cell lung cancer]] and [[gynecological]] [[tumors]]
 
*
|-
|
* [[Encephalitis]]
|
* [[Teratoma]]
|-
|
* [[Polymyositis]]
|
* [[Squamous cell lung cancer]], [[breast cancer]]<ref name="GabrilovichRaza2006">{{cite journal|last1=Gabrilovich|first1=Mikhail|last2=Raza|first2=Mohammad|last3=Dolan|first3=Stephen|last4=Raza|first4=Tasleem|title=Paraneoplastic Polymyositis Associated With Squamous Cell Carcinoma of the Lung|journal=Chest|volume=129|issue=6|year=2006|pages=1721–1723|issn=00123692|doi=10.1378/chest.129.6.1721}}</ref>
|-
|
* [[Autonomic neuropathy]]<ref name="urlParaneoplastic autonomic neuropathy: a case report | GM">{{cite web |url=https://www.gmjournal.co.uk/paraneoplastic-autonomic-neuropathy-a-case-report |title=Paraneoplastic autonomic neuropathy: a case report &#124; GM |format= |work= |accessdate=}}</ref>
|
* [[Carcinomas]],[[small cell lung cancer]], [[thymoma]]
|-
|
* [[Lambert-Eaton myasthenic syndrome]] ([[LEMS]])
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[prostate cancer]], [[lymphomas]], [[adenocarcinomas]]
|-
|
* [[Myasthenia gravis]]
|
* [[Thymoma]]
|-
|
* Subacute (peripheral) [[sensory neuropathy]]
|
* [[Small cell lung cancer]], [[breast cancer]], [[sarcomas]], [[Hodgkin lymphoma]], and [[ovarian cancer]]
|-
| rowspan="4"  align="center" style="background:#f0f0f0;" |[[Hematological]]<ref name="PelosofGerber2010">{{cite journal|last1=Pelosof|first1=Lorraine C.|last2=Gerber|first2=David E.|title=Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment|journal=Mayo Clinic Proceedings|volume=85|issue=9|year=2010|pages=838–854|issn=00256196|doi=10.4065/mcp.2010.0099}}</ref>
|
* [[Granulocytosis]]<ref name="AscensaoOken1987">{{cite journal|last1=Ascensao|first1=Joad L.|last2=Oken|first2=Martin M.|last3=Ewing|first3=Stephen L.|last4=Goldberg|first4=Robert J.|last5=Kaplan|first5=Manuel E.|title=Leukocytosis and large cell lung cancer. A frequent association|journal=Cancer|volume=60|issue=4|year=1987|pages=903–905|issn=0008-543X|doi=10.1002/1097-0142(19870815)60:4<903::AID-CNCR2820600431>3.0.CO;2-6}}</ref><ref name="AhnPark2005">{{cite journal|last1=Ahn|first1=Heui June|last2=Park|first2=Yeon Hee|last3=Chang|first3=Yoon Hwan|last4=Park|first4=Sun Hoo|last5=Kim|first5=Min-Suk|last6=Ryoo|first6=Baek Yeol|last7=Yang|first7=Sung Hyun|title=A Case of Uterine Cervical Cancer Presenting with Granulocytosis|journal=The Korean Journal of Internal Medicine|volume=20|issue=3|year=2005|pages=247|issn=1226-3303|doi=10.3904/kjim.2005.20.3.247}}</ref>
|
* [[Lung cancer]] (particularly [[large cell lung cancer]]), [[Gastrointestinal cancer|gastrointestinal]], [[Brain cancer|brain]], [[Breast cancer|breast]], [[Renal cancer|renal]], and [[gynecologic cancers]]
|-
|
* [[Thrombocytosis]]<ref name="StoneNick2012">{{cite journal|last1=Stone|first1=Rebecca L.|last2=Nick|first2=Alpa M.|last3=McNeish|first3=Iain A.|last4=Balkwill|first4=Frances|last5=Han|first5=Hee Dong|last6=Bottsford-Miller|first6=Justin|last7=Rupaimoole|first7=Rajesha|last8=Armaiz-Pena|first8=Guillermo N.|last9=Pecot|first9=Chad V.|last10=Coward|first10=Jermaine|last11=Deavers|first11=Michael T.|last12=Vasquez|first12=Hernan G.|last13=Urbauer|first13=Diana|last14=Landen|first14=Charles N.|last15=Hu|first15=Wei|last16=Gershenson|first16=Hannah|last17=Matsuo|first17=Koji|last18=Shahzad|first18=Mian M.K.|last19=King|first19=Erin R.|last20=Tekedereli|first20=Ibrahim|last21=Ozpolat|first21=Bulent|last22=Ahn|first22=Edward H.|last23=Bond|first23=Virginia K.|last24=Wang|first24=Rui|last25=Drew|first25=Angela F.|last26=Gushiken|first26=Francisca|last27=Lamkin|first27=Donald|last28=Collins|first28=Katherine|last29=DeGeest|first29=Koen|last30=Lutgendorf|first30=Susan K.|last31=Chiu|first31=Wah|last32=Lopez-Berestein|first32=Gabriel|last33=Afshar-Kharghan|first33=Vahid|last34=Sood|first34=Anil K.|title=Paraneoplastic Thrombocytosis in Ovarian Cancer|journal=New England Journal of Medicine|volume=366|issue=7|year=2012|pages=610–618|issn=0028-4793|doi=10.1056/NEJMoa1110352}}</ref>
|
* [[Ovarian cancer]]
|-
|
* [[Pure red cell aplasia]]<ref name="RosuCohen2011">{{cite journal|last1=Rosu|first1=Cristian|last2=Cohen|first2=Sandra|last3=Meunier|first3=Caroline|last4=Ouellette|first4=Denise|last5=Beauchamp|first5=Gilles|last6=Rakovich|first6=George|title=Pure red cell aplasia and associated thymoma|journal=Clinics and Practice|volume=1|issue=1|year=2011|pages=1|issn=2039-7283|doi=10.4081/cp.2011.e1}}</ref>
|
* [[Thymoma]], [[lymphoma]], [[leukemia]]
|-
|
* [[Eosinophilia]]<ref name="PelosofGerber2010">{{cite journal|last1=Pelosof|first1=Lorraine C.|last2=Gerber|first2=David E.|title=Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment|journal=Mayo Clinic Proceedings|volume=85|issue=9|year=2010|pages=838–854|issn=00256196|doi=10.4065/mcp.2010.0099}}</ref>
|
* [[Lymphomas]], [[leukemias]], [[lung]], [[Gastrointestinal tumor|gastrointestinal]], and [[Genital cancer|gynecologic]] [[tumors]]
|-
| align="center" style="background:#f0f0f0;" |Others
|
* [[Membranous glomerulonephritis]]<ref name="LeeaphornKue-A-Pai2014">{{cite journal|last1=Leeaphorn|first1=Napat|last2=Kue-A-Pai|first2=Pogsathorn|last3=Thamcharoen|first3=Natanong|last4=Ungprasert|first4=Patompong|last5=Stokes|first5=Michael B.|last6=Knight|first6=Eric L.|title=Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies|journal=American Journal of Nephrology|volume=40|issue=1|year=2014|pages=29–35|issn=1421-9670|doi=10.1159/000364782}}</ref>
|
* [[Lung cancer]], [[prostate cancer]], and [[Hematologic malignancy|hematologic malignancies]]
|-
|}


==Overview==
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
'''Paraneoplastic syndromes''' are rare type of [[diseases]] that are caused by abnormal [[immune]] systems resulting from [[cancerous]] cells. Paraneoplastic syndromes are [[disorders]] due to released of [[hormones]], peptitdes then [[immune]] cross-reactivity between [[cancerous]] [[cells]] and normal [[tissues]]. Sometimes the [[symptoms]] of paraneoplastic syndromes show even before the [[diagnosis]] of a [[Malignant|malignancy]].There is no [[screening]] for paraneoplastic syndromes. The stage and type of the diagnosis of the [[cancer]] determine the [[prognosis]] of a paraneoplastic syndrome. The [[causes]] are mostly related to organ affected. The classification of the paraneoplastic syndromes is divided into four main categories such as [[mucocutaneous]], [[neurological]], [[hematological]] and [[Endocrine|endocrines]].The are no cures for paraneoplastic syndrome, but [[cancer]] treatment and some [[medications]] to reduce [[Autoimmunity|autoimmune]] responses are helpful.
|+


==Classification==
|-
Paraneoplastic syndromes may be classified into 4 main categories:
*[[Mucocutaneous]] paraneoplastic syndromes <ref name="pmid9208889">{{cite journal |author=Cohen PR, Kurzrock R |title=Mucocutaneous paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=334–59 |year=1997 |pmid=9208889 |doi=}}</ref>
**[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]])
**[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions
**[[Acanthosis nigricans]]
**[[Necrolytic migratory erythema]]
**[[Sweet's syndrome]]
**[[Pyoderma gangrenosum]]


*[[Neurological]] paraneoplastic syndromes: <ref>{{MeshName|Nervous+system+paraneoplastic+syndromes}}</ref><ref name="pmid19620862">{{cite journal |vauthors=Didelot A, Honnorat J |title=Update on paraneoplastic neurological syndromes |journal=Curr Opin Oncol |volume=21 |issue=6 |pages=566–72 |date=November 2009 |pmid=19620862 |doi=10.1097/CCO.0b013e3283306647 |url=}}</ref>
|-
**[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers
**[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]])
**[[Limbic encephalitis]]
**[[Encephalitis|Brainstem encephalitis]]
**[[Opsoclonus]] (involving eye movement)
**[[Encephalitis]] triggered by a [[teratoma]]<ref name="pmid17262855">{{cite journal |author=Dalmau J, Tüzün E, Wu HY, ''et al'' |title=Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma |journal=Ann. Neurol. |volume=61 |issue=1 |pages=25–36 |year=2007 |month=January |pmid=17262855 |pmc=2430743 |doi=10.1002/ana.21050 |url=}}</ref>
**[[Polymyositis]]
**[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]]
**[[Myasthenia gravis]]
**Subacute (peripheral) [[sensory neuropathy]]
**[[Autonomic neuropathy]]


*[[Hematological]] paraneoplastic syndromes <ref name="pmid9208888">{{cite journal |author=Staszewski H |title=Hematological paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=329–33 |year=1997 |pmid=9208888 |doi=}}</ref><ref name="pmid8400277">{{cite journal |vauthors=Blay JY, Favrot M, Rossi JF, Wijdenes J |title=Role of interleukin-6 in paraneoplastic thrombocytosis |journal=Blood |volume=82 |issue=7 |pages=2261–2 |date=October 1993 |pmid=8400277 |doi= |url=}}</ref>
|-
**[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]]
**[[Eosinophilia]]
**[[Pure red cell aplasia]]
**[[Thrombocytosis]]


*[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]:<ref>{{MeshName|Paraneoplastic+endocrine+syndromes}}</ref><ref name="pmid15673803">{{cite journal |vauthors=Stewart AF |title=Clinical practice. Hypercalcemia associated with cancer |journal=N. Engl. J. Med. |volume=352 |issue=4 |pages=373–9 |date=January 2005 |pmid=15673803 |doi=10.1056/NEJMcp042806 |url=}}</ref><ref name="pmid16337807">{{cite journal |vauthors=Spinazzé S, Schrijvers D |title=Metabolic emergencies |journal=Crit. Rev. Oncol. Hematol. |volume=58 |issue=1 |pages=79–89 |date=April 2006 |pmid=16337807 |doi=10.1016/j.critrevonc.2005.04.004 |url=}}</ref>
|-
**[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically squamous cell) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])
***Seen in multiple [[myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
**[[Syndrome of inappropriate antidiuretic hormone|SIADH]]<ref name="pmid17701059">{{cite journal |vauthors=Raftopoulos H |title=Diagnosis and management of hyponatremia in cancer patients |journal=Support Care Cancer |volume=15 |issue=12 |pages=1341–7 |date=December 2007 |pmid=17701059 |doi=10.1007/s00520-007-0309-9 |url=}}</ref><ref name="pmid17507705">{{cite journal |vauthors=Ellison DH, Berl T |title=Clinical practice. The syndrome of inappropriate antidiuresis |journal=N. Engl. J. Med. |volume=356 |issue=20 |pages=2064–72 |date=May 2007 |pmid=17507705 |doi=10.1056/NEJMcp066837 |url=}}</ref>
***Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
**[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]]
**[[Tumor induced osteomalacia]]
**[[Hypoglycemia]]<ref name="pmid9876347">{{cite journal |vauthors=Teale JD, Marks V |title=Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH) |journal=Clin. Endocrinol. (Oxf) |volume=49 |issue=4 |pages=491–8 |date=October 1998 |pmid=9876347 |doi= |url=}}</ref>
***Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]]


*Others:
|-
**[[Membranous glomerulonephritis]]
==Causes==
===Common Causes===
The major causes of paraneoplastic syndrome include:<ref name="pmid1591305">{{cite journal| author=Richardson GE, Johnson BE| title=Paraneoplastic syndromes in lung cancer. | journal=Curr Opin Oncol | year= 1992 | volume= 4 | issue= 2 | pages= 323-33 | pmid=1591305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1591305  }}</ref><ref name="pmid8946620">{{cite journal| author=Gold PJ, Fefer A, Thompson JA| title=Paraneoplastic manifestations of renal cell carcinoma. | journal=Semin Urol Oncol | year= 1996 | volume= 14 | issue= 4 | pages= 216-22 | pmid=8946620 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8946620  }}</ref><ref name="pmid191296132">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref>


*[[Small cell lung cancer]]
|-
*[[Non-small cell lung cancer]]
*[[Myeloma]]
*[[Breast cancer]]
*[[Medullary thyroid cancer]]
*[[Bronchial]] [[carcinoid]]
*[[Pancoast tumor|Pancoast's tumour]]
*[[Pancreatic cancer]]


===Causes by Organ System===
|-
*Paraneoplastic syndromes causes may be regrouped by organ system.<ref name="pmid20810794">{{cite journal| author=Pelosof LC, Gerber DE| title=Paraneoplastic syndromes: an approach to diagnosis and treatment. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 9 | pages= 838-54 | pmid=20810794 | doi=10.4065/mcp.2010.0099 | pmc=2931619 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20810794  }} </ref>


{| style="width:82%; height:100px" border="1"
|-


|-
|-


|- bgcolor="LightSteelBlue"
|-


| '''[[List of skin diseases|Dermatologic]]'''
|-


| bgcolor="Beige" |[[Dermatomyositis]], [[Cutaneous T-cell lymphoma]]
|}


==Causes==
===Common Causes===
* The major [[causes]] of paraneoplastic syndrome include:<ref name="pmid1591305">{{cite journal| author=Richardson GE, Johnson BE| title=Paraneoplastic syndromes in lung cancer. | journal=Curr Opin Oncol | year= 1992 | volume= 4 | issue= 2 | pages= 323-33 | pmid=1591305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1591305  }}</ref><ref name="pmid8946620">{{cite journal| author=Gold PJ, Fefer A, Thompson JA| title=Paraneoplastic manifestations of renal cell carcinoma. | journal=Semin Urol Oncol | year= 1996 | volume= 14 | issue= 4 | pages= 216-22 | pmid=8946620 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8946620  }}</ref><ref name="pmid191296132">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref>
**[[Small cell lung cancer]]
** [[Non-small cell lung cancer]]
** [[Multiple myeloma]]
** [[Breast cancer]]
** [[Medullary thyroid cancer]]
** [[Bronchial]] [[carcinoid]]
** [[Pancoast tumor|Pancoast's tumour]]
** [[Pancreatic cancer]]
** [[Hepatocellular carcinoma]]
** [[Gastric tumors]]
** [[Gastrointestinal]] [[neuroendocrine tumors]] (NETS)
** [[Leukemias]]
** [[Lymphomas]]
** [[Skin cancers]]
** [[Renal carcinoma]]
===Causes by Organ System===
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system.<ref name="pmid20810794">{{cite journal| author=Pelosof LC, Gerber DE| title=Paraneoplastic syndromes: an approach to diagnosis and treatment. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 9 | pages= 838-54 | pmid=20810794 | doi=10.4065/mcp.2010.0099 | pmc=2931619 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20810794  }} </ref><ref name="pmid30876820">{{cite journal |vauthors=Henry K |title=Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment |journal=Semin Diagn Pathol |volume=36 |issue=4 |pages=204–210 |date=July 2019 |pmid=30876820 |doi=10.1053/j.semdp.2019.01.002 |url=}}</ref>
{| style="width:82%; height:100px" border="1"
|-
|- bgcolor="LightSteelBlue"
| '''[[List of skin diseases|Dermatologic]]'''
| bgcolor="Beige" |
* [[Dermatomyositis]]
* [[Cutaneous T-cell lymphoma]]
|-
|-


Line 83: Line 247:
| '''[[ENT|Ear Nose Throat]]'''
| '''[[ENT|Ear Nose Throat]]'''


| bgcolor="Beige" |[[Oropharyngeal]] [[cancer]]
| bgcolor="Beige" |
* [[Oropharyngeal]] [[cancer]]


|-  
|-  
Line 91: Line 256:
| '''[[Endocrine system|Endocrine]]'''
| '''[[Endocrine system|Endocrine]]'''


| bgcolor="Beige" |[[Medullary thyroid cancer]], [[Adrenal cancer]]
| bgcolor="Beige" |
* [[Medullary thyroid cancer]]
* [[Adrenal cancer]]


|-
|-
Line 99: Line 266:
| '''[[Gastroenterology|Gastroenterologic]]'''
| '''[[Gastroenterology|Gastroenterologic]]'''


| bgcolor="Beige" |[[Pancreatic cancer]]Other [[Gastrointestinal tract|GI]] [[cancers]]
| bgcolor="Beige" |
* [[Pancreatic cancer]]
* Other [[Gastrointestinal tract|GI]] [[cancers]]


|-
|-
Line 107: Line 276:
| '''[[Hematology|Hematologic]]'''
| '''[[Hematology|Hematologic]]'''


| bgcolor="Beige" |[[Myeloproliferative disorders]], [[Myeloma]], [[Melanoma]], [[Lymphoma]], [[Human T-lymphotropic virus|HTLV]]-associated [[Lymphoma]], [[Hodgkin's lymphoma]], [[Chronic lymphocytic leukemia]], [[Cancer|Cancers]] of the [[T-cells]] , [[Adult T-cell leukemia]], [[Acute myeloid leukemia]],
| bgcolor="Beige" |
* [[Myeloproliferative disorders]],
*[[Multiple myeloma]], [[Melanoma]]
* [[Lymphoma]]
* [[Human T-lymphotropic virus|HTLV]]-associated [[Lymphoma]]
* [[Hodgkin's lymphoma]]
* [[Chronic lymphocytic leukemia]]
* [[Cancer|Cancers]] of the [[T-cells]]  
* [[Adult T-cell leukemia]]
* [[Acute myeloid leukemia]]


|-
|-
Line 115: Line 293:
| '''[[Musculoskeletal system|Musculoskeletal]]/[[Orthopedics|Orthopedic]]'''
| '''[[Musculoskeletal system|Musculoskeletal]]/[[Orthopedics|Orthopedic]]'''


| bgcolor="Beige" |[[Teratoma]], [[Sarcomas]], [[Ewing sarcoma ]]
| bgcolor="Beige" |
* [[Teratoma]]
* [[Sarcomas]]
* [[Ewing sarcoma]]


|-
|-
Line 123: Line 304:
| '''[[Neurology|Neurologic]]'''
| '''[[Neurology|Neurologic]]'''


| bgcolor="Beige" |[[Brain Cancer]]
| bgcolor="Beige" |
* [[Brain Cancer]]


|-
|-
Line 131: Line 313:
| '''[[Obstetrics and Gynaecology|Obstetric/Gynecologic]]'''
| '''[[Obstetrics and Gynaecology|Obstetric/Gynecologic]]'''


| bgcolor="Beige" |[[ovarian cancer]], [[Endometrial cancer]]
| bgcolor="Beige" |
* [[Ovarian cancer]]
* [[Endometrial cancer]]


|-
|-
Line 139: Line 323:
| '''[[Oncology|Oncologic]]'''
| '''[[Oncology|Oncologic]]'''


| bgcolor="Beige" |[[Breast cancer]]
| bgcolor="Beige" |
* [[Breast cancer]]


|-
|-
Line 147: Line 332:
| '''[[Lung|Pulmonary]]'''
| '''[[Lung|Pulmonary]]'''


| bgcolor="Beige" |[[Small cell lung cancer]], [[Pancoast tumor|Pancoast's tumour]], [[Oat cell carcinoma]], [[Non-small cell lung cancer]], [[Malignant Mesothelioma]], [[Bronchiole|Bronchial]] [[carcinoid]]
| bgcolor="Beige" |
* [[Small cell lung cancer]]
* [[Pancoast tumor|Pancoast's tumour]]
* [[Oat cell carcinoma]]
* [[Non-small cell lung cancer]]
* [[Malignant Mesothelioma]]
* [[Bronchiole|Bronchial]] [[carcinoid]]


|-
|-
Line 155: Line 346:
| '''[[Renal]][[Electrolyte|/Electrolyte]]'''
| '''[[Renal]][[Electrolyte|/Electrolyte]]'''


| bgcolor="Beige" |[[Kidney cancer]]
| bgcolor="Beige" |
* [[Kidney cancer|Renal cancer]]


|-
|-
Line 163: Line 355:
| '''[[Rheumatology]][[Immunology|/Immunology]]/[[Allergy]]'''
| '''[[Rheumatology]][[Immunology|/Immunology]]/[[Allergy]]'''


| bgcolor="Beige" | No underlying causes
| bgcolor="Beige" |
* No underlying causes


|-
|-
Line 171: Line 364:
| '''[[Urology|Urologic]]'''
| '''[[Urology|Urologic]]'''


| bgcolor="Beige" |[[Ureteral]] [[cancer]], [[Prostate cancer]], [[Bladder cancer]]
| bgcolor="Beige" |
* [[Ureteral]] [[cancer]]
 
* [[Prostate cancer]]
 
* [[Bladder cancer]]


|-
|-
Line 179: Line 377:
| '''Miscellaneous'''
| '''Miscellaneous'''


| bgcolor="Beige" |[[Thymoma]], [[Testicular]] [[Germ Cell Tumor|germ-cell tumors]]
| bgcolor="Beige" |
* [[Thymoma]]
 
* [[Testicular]] [[Germ Cell Tumor|germ-cell tumors]]


|-
|-
Line 186: Line 387:


==Differential diagnosis==
==Differential diagnosis==
Paraneoplastic syndromes must be differentiated from others types of [[cancer]] depending on the location and type of organs.
Paraneoplastic syndromes must be [[Differentiate|differentiated]] from others types of [[cancer]] depending on the location and type of organs.
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
Line 215: Line 416:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Small cell lung cancer]]<ref name="NCCN">[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014]</ref><ref name="CarterGlisson2014">{{cite journal|last1=Carter|first1=Brett W.|last2=Glisson|first2=Bonnie S.|last3=Truong|first3=Mylene T.|last4=Erasmus|first4=Jeremy J.|title=Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations|journal=RadioGraphics|volume=34|issue=6|year=2014|pages=1707–1721|issn=0271-5333|doi=10.1148/rg.346140178}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]<ref name="NCCN">[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014]</ref><ref name="CarterGlisson2014">{{cite journal|last1=Carter|first1=Brett W.|last2=Glisson|first2=Bonnie S.|last3=Truong|first3=Mylene T.|last4=Erasmus|first4=Jeremy J.|title=Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations|journal=RadioGraphics|volume=34|issue=6|year=2014|pages=1707–1721|issn=0271-5333|doi=10.1148/rg.346140178}}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Cough]]
* [[Cough]]
Line 250: Line 451:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Squamous cell carcinoma of the lung|Squamous lung cancer]]<ref name="Rosado-de-ChristensonTempleton1994">{{cite journal|last1=Rosado-de-Christenson|first1=M L|last2=Templeton|first2=P A|last3=Moran|first3=C A|title=Bronchogenic carcinoma: radiologic-pathologic correlation.|journal=RadioGraphics|volume=14|issue=2|year=1994|pages=429–446|issn=0271-5333|doi=10.1148/radiographics.14.2.8190965}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]<ref name="Rosado-de-ChristensonTempleton1994">{{cite journal|last1=Rosado-de-Christenson|first1=M L|last2=Templeton|first2=P A|last3=Moran|first3=C A|title=Bronchogenic carcinoma: radiologic-pathologic correlation.|journal=RadioGraphics|volume=14|issue=2|year=1994|pages=429–446|issn=0271-5333|doi=10.1148/radiographics.14.2.8190965}}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]]  at first
* [[Asymptomatic]]  at first
Line 265: Line 466:


* [[Lymphadenopathy]]
* [[Lymphadenopathy]]
* [[Fingers]] [[clubbing]]


<br />
<br />
Line 272: Line 471:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Decreased [[breath sound]] in lung auscultation
* Decreased [[breath sound]] in lung auscultation
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |
* [[Fingers]] [[clubbing]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[Calcium|Ca++]]
* ↑ [[Calcium|Ca++]]
Line 289: Line 489:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatocellular carcinoma]]<ref name="ReynoldsFurlan2015">{{cite journal|last1=Reynolds|first1=Arich R.|last2=Furlan|first2=Alessandro|last3=Fetzer|first3=David T.|last4=Sasatomi|first4=Eizaburo|last5=Borhani|first5=Amir A.|last6=Heller|first6=Matthew T.|last7=Tublin|first7=Mitchell E.|title=Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know|journal=RadioGraphics|volume=35|issue=2|year=2015|pages=371–386|issn=0271-5333|doi=10.1148/rg.352140114}}</ref><ref name="FloresLang2011">{{cite journal|last1=Flores|first1=Yvonne N.|last2=Lang|first2=Cathy M.|last3=Salmerón|first3=Jorge|last4=Bastani|first4=Roshan|title=Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico|journal=Journal of Community Health|volume=37|issue=2|year=2011|pages=403–411|issn=0094-5145|doi=10.1007/s10900-011-9457-4}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]<ref name="ReynoldsFurlan2015">{{cite journal|last1=Reynolds|first1=Arich R.|last2=Furlan|first2=Alessandro|last3=Fetzer|first3=David T.|last4=Sasatomi|first4=Eizaburo|last5=Borhani|first5=Amir A.|last6=Heller|first6=Matthew T.|last7=Tublin|first7=Mitchell E.|title=Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know|journal=RadioGraphics|volume=35|issue=2|year=2015|pages=371–386|issn=0271-5333|doi=10.1148/rg.352140114}}</ref><ref name="FloresLang2011">{{cite journal|last1=Flores|first1=Yvonne N.|last2=Lang|first2=Cathy M.|last3=Salmerón|first3=Jorge|last4=Bastani|first4=Roshan|title=Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico|journal=Journal of Community Health|volume=37|issue=2|year=2011|pages=403–411|issn=0094-5145|doi=10.1007/s10900-011-9457-4}}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first
Line 305: Line 505:
* [[Jaundice]]  
* [[Jaundice]]  
* [[Cachexia]]
* [[Cachexia]]
* [[Ascites]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Splenomegaly]]
* [[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
* [[Ascite|Abdominal swelling with fluid shift]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[PT|Prolonged  PT]]
* [[PT|Prolonged  PT]]
Line 343: Line 543:
!Additional findings
!Additional findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast cancer]]<ref name="Mišković2016">{{cite journal|last1=Mišković|first1=Josip|title=DIAGNOSTIC VALUE OF FINE NEEDLE ASPIRATION CYTOLOGY FOR BREAST TUMORS|journal=ACTA CLINICA CROATICA|year=2016|pages=625–628|issn=03539466|doi=10.20471/acc.2016.55.04.13}}</ref><ref name="pmid29117654">{{cite journal| author=Mišković J, Zorić A, Radić Mišković H, Šoljić V| title=Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors | journal=Acta Clin Croat | year= 2016 | volume= 55 | issue= 4 | pages= 625-628 | pmid=29117654 | doi=10.20471/acc.2016.55.04.13 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29117654  }}</ref><ref name="pmid8004594">{{cite journal| author=McKenna RJ| title=The abnormal mammogram radiographic findings, diagnostic options, pathology, and stage of cancer diagnosis. | journal=Cancer | year= 1994 | volume= 74 | issue= 1 Suppl | pages= 244-55 | pmid=8004594 | doi=10.1002/cncr.2820741308 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8004594  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]<ref name="Mišković2016">{{cite journal|last1=Mišković|first1=Josip|title=DIAGNOSTIC VALUE OF FINE NEEDLE ASPIRATION CYTOLOGY FOR BREAST TUMORS|journal=ACTA CLINICA CROATICA|year=2016|pages=625–628|issn=03539466|doi=10.20471/acc.2016.55.04.13}}</ref><ref name="pmid29117654">{{cite journal| author=Mišković J, Zorić A, Radić Mišković H, Šoljić V| title=Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors | journal=Acta Clin Croat | year= 2016 | volume= 55 | issue= 4 | pages= 625-628 | pmid=29117654 | doi=10.20471/acc.2016.55.04.13 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29117654  }}</ref><ref name="pmid8004594">{{cite journal| author=McKenna RJ| title=The abnormal mammogram radiographic findings, diagnostic options, pathology, and stage of cancer diagnosis. | journal=Cancer | year= 1994 | volume= 74 | issue= 1 Suppl | pages= 244-55 | pmid=8004594 | doi=10.1002/cncr.2820741308 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8004594  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Lump]] in the [[breast]]
* [[Lump]] in the [[breast]]
Line 358: Line 558:
* Dimpling of [[skin]] [[Nipples|Inverted nipples]]
* Dimpling of [[skin]] [[Nipples|Inverted nipples]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Bloody [[nipple discharge]], Change in [[Personality changes|personality]]
* Bloody [[nipple discharge]]
*Change in [[Personality changes|personality]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
Line 373: Line 574:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Biopsy]]
* [[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal cell carcinoma|Renal cancer]]<ref name="CairnsSrivastava2011">{{cite journal|last1=Cairns|first1=Paul|last2=Srivastava|first2=Sudhir|last3=Grizzle|first3=William E.|title=Renal cell carcinoma|journal=Cancer Biomarkers|volume=9|issue=1-6|year=2011|pages=461–473|issn=18758592|doi=10.3233/CBM-2011-0176}}</ref><ref name="pmid7769125">{{cite journal| author=de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR et al.| title=Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. | journal=J Clin Invest | year= 1995 | volume= 95 | issue= 6 | pages= 2846-52 | pmid=7769125 | doi=10.1172/JCI117990 | pmc=295971 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7769125  }}</ref><ref name="pmid3306861">{{cite journal| author=Laski ME, Vugrin D| title=Paraneoplastic syndromes in hypernephroma. | journal=Semin Nephrol | year= 1987 | volume= 7 | issue= 2 | pages= 123-30 | pmid=3306861 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3306861  }}</ref><ref name="pmid20479778">{{cite journal| author=Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N| title=Imaging renal cell carcinoma with ultrasonography, CT and MRI. | journal=Nat Rev Urol | year= 2010 | volume= 7 | issue= 6 | pages= 311-25 | pmid=20479778 | doi=10.1038/nrurol.2010.63 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479778  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]<ref name="CairnsSrivastava2011">{{cite journal|last1=Cairns|first1=Paul|last2=Srivastava|first2=Sudhir|last3=Grizzle|first3=William E.|title=Renal cell carcinoma|journal=Cancer Biomarkers|volume=9|issue=1-6|year=2011|pages=461–473|issn=18758592|doi=10.3233/CBM-2011-0176}}</ref><ref name="pmid7769125">{{cite journal| author=de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR et al.| title=Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. | journal=J Clin Invest | year= 1995 | volume= 95 | issue= 6 | pages= 2846-52 | pmid=7769125 | doi=10.1172/JCI117990 | pmc=295971 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7769125  }}</ref><ref name="pmid3306861">{{cite journal| author=Laski ME, Vugrin D| title=Paraneoplastic syndromes in hypernephroma. | journal=Semin Nephrol | year= 1987 | volume= 7 | issue= 2 | pages= 123-30 | pmid=3306861 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3306861  }}</ref><ref name="pmid20479778">{{cite journal| author=Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N| title=Imaging renal cell carcinoma with ultrasonography, CT and MRI. | journal=Nat Rev Urol | year= 2010 | volume= 7 | issue= 6 | pages= 311-25 | pmid=20479778 | doi=10.1038/nrurol.2010.63 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479778  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Hematuria]]
* [[Hematuria]]
Line 395: Line 596:
* [[Pallor]]
* [[Pallor]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[Calcium|ca++]]  
* ↑ [[Ca|Ca++]]
* [[Polycythemia]]  
* [[Polycythemia]]  
* ↑ [[platelets]]
* ↑ [[Platelets]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[ALP]]
* ↑ [[ALP]]
Line 403: Line 604:
* ↑ [[LDH]]
* ↑ [[LDH]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[creatinine]]  
* ↑ [[Creatinine]]  
* ↑ [[cancer cells]] in [[Urine|urine cytology]]
* ↑ [[Cancer cells]] in [[Urine|urine cytology]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Abdominal]] CT scan:  
* [[Abdominal]] CT scan:  
Line 415: Line 616:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Biopsy|Needle Biopsy]]
* [[Biopsy|Needle Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pancreatic cancer]]<ref name="pmid19129613">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref><ref name="pmid15960930">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930  }}</ref><ref name="HollyChaliha2004">{{cite journal|last1=Holly|first1=Elizabeth A.|last2=Chaliha|first2=Indranushi|last3=Bracci|first3=Paige M.|last4=Gautam|first4=Manjushree|title=Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area|journal=Clinical Gastroenterology and Hepatology|volume=2|issue=6|year=2004|pages=510–517|issn=15423565|doi=10.1016/S1542-3565(04)00171-5}}</ref><ref name="pmid26495795">{{cite journal| author=Schmidt-Hansen M, Berendse S, Hamilton W| title=Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. | journal=Pancreas | year= 2016 | volume= 45 | issue= 6 | pages= 814-8 | pmid=26495795 | doi=10.1097/MPA.0000000000000527 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26495795  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]<ref name="pmid19129613">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref><ref name="pmid15960930">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930  }}</ref><ref name="HollyChaliha2004">{{cite journal|last1=Holly|first1=Elizabeth A.|last2=Chaliha|first2=Indranushi|last3=Bracci|first3=Paige M.|last4=Gautam|first4=Manjushree|title=Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area|journal=Clinical Gastroenterology and Hepatology|volume=2|issue=6|year=2004|pages=510–517|issn=15423565|doi=10.1016/S1542-3565(04)00171-5}}</ref><ref name="pmid26495795">{{cite journal| author=Schmidt-Hansen M, Berendse S, Hamilton W| title=Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. | journal=Pancreas | year= 2016 | volume= 45 | issue= 6 | pages= 814-8 | pmid=26495795 | doi=10.1097/MPA.0000000000000527 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26495795  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Epigastric]] [[pain]]
* [[Epigastric]] [[pain]]
Line 429: Line 630:
* [[Loss of appetite]]
* [[Loss of appetite]]
* [[Greasy stools]]
* [[Greasy stools]]
* [[Asthenia]]
*[[Lack of energy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Cachexia]]  
* [[Cachexia]]  
Line 439: Line 640:
* [[Palpable|Palpable periumbilical]] [[mass]]
* [[Palpable|Palpable periumbilical]] [[mass]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[bilirubin]]
* ↑ [[Bilirubin]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[ALP]]
* ↑ [[ALP]]
Line 459: Line 660:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Spiral CT scan|Spiral CT scan with contrast]]
* [[Spiral CT scan|Spiral CT scan with contrast]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gastric cancer]]<ref name="pmid23667204">{{cite journal| author=Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C et al.| title=Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 5 | pages= 531-46 | pmid=23667204 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23667204  }}</ref><ref name="pmid8239772">{{cite journal| author=Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R| title=Cancer of the stomach. A patient care study by the American College of Surgeons. | journal=Ann Surg | year= 1993 | volume= 218 | issue= 5 | pages= 583-92 | pmid=8239772 | doi=10.1097/00000658-199321850-00002 | pmc=1243028 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8239772  }}</ref><ref name="pmid3357941">{{cite journal| author=Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM et al.| title=Gastric adenocarcinoma: CT versus surgical staging. | journal=Radiology | year= 1988 | volume= 167 | issue= 2 | pages= 335-40 | pmid=3357941 | doi=10.1148/radiology.167.2.3357941 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3357941  }}</ref><ref name="pmid7859977">{{cite journal| author=Karita M, Tada M| title=Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. | journal=Gastrointest Endosc | year= 1994 | volume= 40 | issue= 6 | pages= 749-53 | pmid=7859977 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7859977  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]<ref name="pmid23667204">{{cite journal| author=Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C et al.| title=Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 5 | pages= 531-46 | pmid=23667204 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23667204  }}</ref><ref name="pmid8239772">{{cite journal| author=Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R| title=Cancer of the stomach. A patient care study by the American College of Surgeons. | journal=Ann Surg | year= 1993 | volume= 218 | issue= 5 | pages= 583-92 | pmid=8239772 | doi=10.1097/00000658-199321850-00002 | pmc=1243028 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8239772  }}</ref><ref name="pmid3357941">{{cite journal| author=Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM et al.| title=Gastric adenocarcinoma: CT versus surgical staging. | journal=Radiology | year= 1988 | volume= 167 | issue= 2 | pages= 335-40 | pmid=3357941 | doi=10.1148/radiology.167.2.3357941 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3357941  }}</ref><ref name="pmid7859977">{{cite journal| author=Karita M, Tada M| title=Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. | journal=Gastrointest Endosc | year= 1994 | volume= 40 | issue= 6 | pages= 749-53 | pmid=7859977 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7859977  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of [[gastric ulcer]]  
* History of [[gastric ulcer]]  
Line 482: Line 683:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[CA 19-9]]
* ↑ [[CA 19-9]]
| style="background: #F5F5F5; padding: 5px;" |
* [[Anemia]]<br />
* [[Anemia]]<br />
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 507: Line 708:
* [[Acanthosis nigricans]]
* [[Acanthosis nigricans]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphoma]]<ref name="pmid15245605">{{cite journal| author=Hagler KT, Lynch JW| title=Paraneoplastic manifestations of lymphoma. | journal=Clin Lymphoma | year= 2004 | volume= 5 | issue= 1 | pages= 29-36 | pmid=15245605 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15245605  }}</ref><ref name="pmid21339498">{{cite journal| author=Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC et al.| title=Spectrum of paraneoplastic disease associated with lymphoma. | journal=Neurology | year= 2011 | volume= 76 | issue= 8 | pages= 705-10 | pmid=21339498 | doi=10.1212/WNL.0b013e31820d62eb | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21339498  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]]<ref name="pmid15245605">{{cite journal| author=Hagler KT, Lynch JW| title=Paraneoplastic manifestations of lymphoma. | journal=Clin Lymphoma | year= 2004 | volume= 5 | issue= 1 | pages= 29-36 | pmid=15245605 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15245605  }}</ref><ref name="pmid21339498">{{cite journal| author=Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC et al.| title=Spectrum of paraneoplastic disease associated with lymphoma. | journal=Neurology | year= 2011 | volume= 76 | issue= 8 | pages= 705-10 | pmid=21339498 | doi=10.1212/WNL.0b013e31820d62eb | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21339498  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Weight loss]]
* [[Weight loss]]
Line 518: Line 719:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Lymphadenopathy]]
* [[Lymphadenopathy]]
| style="background: #F5F5F5; padding: 5px;" |
* [[Hepatosplenomegaly]]
* [[Hepatosplenomegaly]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[LDH]]
* ↑ [[LDH]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 534: Line 735:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Biopsy]]
* [[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ovarian cancer]]<ref name="pmid22217630">{{cite journal| author=Hippisley-Cox J, Coupland C| title=Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. | journal=BMJ | year= 2011 | volume= 344 | issue=  | pages= d8009 | pmid=22217630 | doi=10.1136/bmj.d8009 | pmc=3251328 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22217630  }}</ref><ref name="pmid22405464">{{cite journal| author=Li J, Fadare O, Xiang L, Kong B, Zheng W| title=Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. | journal=J Hematol Oncol | year= 2012 | volume= 5 | issue=  | pages= 8 | pmid=22405464 | doi=10.1186/1756-8722-5-8 | pmc=3328281 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22405464  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]<ref name="pmid22217630">{{cite journal| author=Hippisley-Cox J, Coupland C| title=Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. | journal=BMJ | year= 2011 | volume= 344 | issue=  | pages= d8009 | pmid=22217630 | doi=10.1136/bmj.d8009 | pmc=3251328 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22217630  }}</ref><ref name="pmid22405464">{{cite journal| author=Li J, Fadare O, Xiang L, Kong B, Zheng W| title=Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. | journal=J Hematol Oncol | year= 2012 | volume= 5 | issue=  | pages= 8 | pmid=22405464 | doi=10.1186/1756-8722-5-8 | pmc=3328281 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22405464  }}</ref>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first
* Unexplained [[thromboses]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Abdominal pain]]
* [[Abdominal pain]]
* Bloating
*[[Bloating]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Early satiety]]
* [[Early satiety]]
Line 548: Line 748:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable [[adnexal]] [[mass]]
* Palpable [[adnexal]] [[mass]]
* [[Ascites]]
*[[Ascites|Abdominal swelling with fluid shift]]
* [[Pleural effusion]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Leg [[swelling]] and [[tenderness]]
* Leg [[swelling]] and [[tenderness]]
Line 556: Line 755:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[CA-125]]
* ↑ [[CA-125]]
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[Calcium|Ca++]]
* ↑ [[Calcium|Ca++]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 569: Line 768:
* [[Psammoma body|Psammoma bodies]]
* [[Psammoma body|Psammoma bodies]]
* [[Necrosis]]
* [[Necrosis]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Trousseau's syndrome|Trousseau]][[syndrome]]
* [[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
* [[Trousseau's syndrome|Trousseau]] [[syndrome]]
|}
|}
==References==
==References==
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category: (name of the system)]]
==References==
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
Line 593: Line 779:
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Needs content]]
[[Category:Needs content]]
 
<references />
==References==

Latest revision as of 15:14, 14 October 2019

For patient information, click here

Paraneoplastic syndrome Microchapters

Patient Information

Overview

Classification

Endocrine
Musculocutaneous
Neurological
Hematological
Others

Causes

Differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]
Synonyms and keywords: Paraneoplastic syndrome

Overview

Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.

Classification

  • Paraneoplastic syndromes may be classified into 5 main categories accordingly:
Type of paraneoplastic syndrome Subtype Associated Cancers
Endocrine
Musculocutaneous
Neurological[11]
Hematological[11]
Others

Causes

Common Causes

Causes by Organ System

  • Paraneoplastic syndromes causes may be regrouped by organ system.[26][27]
Dermatologic
Ear Nose Throat
Endocrine
Gastroenterologic
Hematologic
Musculoskeletal/Orthopedic
Neurologic
Obstetric/Gynecologic
Oncologic
Pulmonary
Renal/Electrolyte
Rheumatology/Immunology/Allergy
  • No underlying causes
Urologic
Miscellaneous

Differential diagnosis

Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Small cell lung cancer[28][29] _ _ Small, round and oval cells

Necrosis

Biopsy _
Squamous lung cancer[30]


_ _ _ _
Hepatocellular carcinoma[31][32] _ _ _ _
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Breast cancer[33][34][35] _ _ _ _ _ _
Renal cancer[36][37][38][39] _ _
  • Depends on the subtypes
_
Pancreatic cancer[40][41][42][43] _
  • U/S: hypoechoic mass
_
Gastric cancer[44][45][46][47]


_ _ _
Lymphoma][48][49] _ _ _ _
  • Depends on the type of lymphoma
_
Ovarian cancer[50][51] _ _

References

  1. Stewart, Andrew F. (2005). "Hypercalcemia Associated with Cancer". New England Journal of Medicine. 352 (4): 373–379. doi:10.1056/NEJMcp042806. ISSN 0028-4793.
  2. Raftopoulos, Harry (2007). "Diagnosis and management of hyponatremia in cancer patients". Supportive Care in Cancer. 15 (12): 1341–1347. doi:10.1007/s00520-007-0309-9. ISSN 0941-4355.
  3. Barbosa, Sandrine Laboureau-Soares; Rodien, Patrice; Leboulleux, Sophie; Niccoli-Sire, Patricia; Kraimps, Jean-Louis; Caron, Philippe; Archambeaud-Mouveroux, Françoise; Conte-Devolx, Bernard; Rohmer, Vincent (2005). "Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature". Thyroid. 15 (6): 618–623. doi:10.1089/thy.2005.15.618. ISSN 1050-7256.
  4. Florenzano, Pablo; Gafni, Rachel I.; Collins, Michael T. (2017). "Tumor-induced osteomalacia". Bone Reports. 7: 90–97. doi:10.1016/j.bonr.2017.09.002. ISSN 2352-1872.
  5. Nauck, Michael A.; Reinecke, Manfred; Perren, Aurel; Frystyk, Jan; Berishvili, Giorgi; Zwimpfer, Cornelia; Figge, Anja M.; Flyvbjerg, Allan; Lankisch, Paul G.; Blum, Werner F.; Klöppel, Günter; Schmiegel, Wolff; Zapf, Jürgen (2007). "Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I in a Patient with Metastasizing Large-Cell Carcinoma of the Lung". The Journal of Clinical Endocrinology & Metabolism. 92 (5): 1600–1605. doi:10.1210/jc.2006-2573. ISSN 0021-972X.
  6. 6.0 6.1 Thiers, B. H.; Sahn, R. E.; Callen, J. P. (2009). "Cutaneous Manifestations of Internal Malignancy". CA: A Cancer Journal for Clinicians. 59 (2): 73–98. doi:10.3322/caac.20005. ISSN 0007-9235.
  7. Gaduputi, Vinaya; Chandrala, Chaitanya; Tariq, Hassan; Kanneganti, Kalyan (2014). "Sign of Leser-Trélat Associated with Esophageal Squamous Cell Cancer". Case Reports in Oncological Medicine. 2014: 1–3. doi:10.1155/2014/825929. ISSN 2090-6706.
  8. Tremblay, Catherine; Marcil, Isabelle (2017). "Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition". Journal of Cutaneous Medicine and Surgery. 21 (6): 559–561. doi:10.1177/1203475417719051. ISSN 1203-4754.
  9. Cohen, Philip R.; Kurzrock, Razelle (1987). "Sweet's syndrome and malignancy". The American Journal of Medicine. 82 (6): 1220–1226. doi:10.1016/0002-9343(87)90229-4. ISSN 0002-9343.
  10. You, Hye Rin; Ju, Jae-Kyun; Yun, Sook Jung; Lee, Jee-Bum; Kim, Seong-Jin; Won, Young Ho; Lee, Seung-Chul (2018). "Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma". Annals of Dermatology. 30 (1): 79. doi:10.5021/ad.2018.30.1.79. ISSN 1013-9087.
  11. 11.0 11.1 11.2 11.3 Pelosof, Lorraine C.; Gerber, David E. (2010). "Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment". Mayo Clinic Proceedings. 85 (9): 838–854. doi:10.4065/mcp.2010.0099. ISSN 0025-6196.
  12. Abdulaziz, Ammar Taha Abdullah; Yu, Xiao Qing; Zhang, Le; Jiang, Xin Yue; Zhou, Dong; Li, Jin Mei (2018). "Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism". Medicine. 97 (24): e10717. doi:10.1097/MD.0000000000010717. ISSN 0025-7974.
  13. Graus, F. (2001). "Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients". Brain. 124 (6): 1138–1148. doi:10.1093/brain/124.6.1138. ISSN 1460-2156.
  14. Shen, Kaini; Xu, Yan; Guan, Hongzhi; Zhong, Wei; Chen, Minjiang; Zhao, Jing; Li, Longyun; Wang, Mengzhao (2018). "Paraneoplastic limbic encephalitis associated with lung cancer". Scientific Reports. 8 (1). doi:10.1038/s41598-018-25294-y. ISSN 2045-2322.
  15. 15.0 15.1 Blaes, Franz (2013). "Paraneoplastic Brain Stem Encephalitis". Current Treatment Options in Neurology. 15 (2): 201–209. doi:10.1007/s11940-013-0221-1. ISSN 1092-8480.
  16. Gabrilovich, Mikhail; Raza, Mohammad; Dolan, Stephen; Raza, Tasleem (2006). "Paraneoplastic Polymyositis Associated With Squamous Cell Carcinoma of the Lung". Chest. 129 (6): 1721–1723. doi:10.1378/chest.129.6.1721. ISSN 0012-3692.
  17. "Paraneoplastic autonomic neuropathy: a case report | GM".
  18. Ascensao, Joad L.; Oken, Martin M.; Ewing, Stephen L.; Goldberg, Robert J.; Kaplan, Manuel E. (1987). "Leukocytosis and large cell lung cancer. A frequent association". Cancer. 60 (4): 903–905. doi:10.1002/1097-0142(19870815)60:4<903::AID-CNCR2820600431>3.0.CO;2-6. ISSN 0008-543X.
  19. Ahn, Heui June; Park, Yeon Hee; Chang, Yoon Hwan; Park, Sun Hoo; Kim, Min-Suk; Ryoo, Baek Yeol; Yang, Sung Hyun (2005). "A Case of Uterine Cervical Cancer Presenting with Granulocytosis". The Korean Journal of Internal Medicine. 20 (3): 247. doi:10.3904/kjim.2005.20.3.247. ISSN 1226-3303.
  20. Stone, Rebecca L.; Nick, Alpa M.; McNeish, Iain A.; Balkwill, Frances; Han, Hee Dong; Bottsford-Miller, Justin; Rupaimoole, Rajesha; Armaiz-Pena, Guillermo N.; Pecot, Chad V.; Coward, Jermaine; Deavers, Michael T.; Vasquez, Hernan G.; Urbauer, Diana; Landen, Charles N.; Hu, Wei; Gershenson, Hannah; Matsuo, Koji; Shahzad, Mian M.K.; King, Erin R.; Tekedereli, Ibrahim; Ozpolat, Bulent; Ahn, Edward H.; Bond, Virginia K.; Wang, Rui; Drew, Angela F.; Gushiken, Francisca; Lamkin, Donald; Collins, Katherine; DeGeest, Koen; Lutgendorf, Susan K.; Chiu, Wah; Lopez-Berestein, Gabriel; Afshar-Kharghan, Vahid; Sood, Anil K. (2012). "Paraneoplastic Thrombocytosis in Ovarian Cancer". New England Journal of Medicine. 366 (7): 610–618. doi:10.1056/NEJMoa1110352. ISSN 0028-4793.
  21. Rosu, Cristian; Cohen, Sandra; Meunier, Caroline; Ouellette, Denise; Beauchamp, Gilles; Rakovich, George (2011). "Pure red cell aplasia and associated thymoma". Clinics and Practice. 1 (1): 1. doi:10.4081/cp.2011.e1. ISSN 2039-7283.
  22. Leeaphorn, Napat; Kue-A-Pai, Pogsathorn; Thamcharoen, Natanong; Ungprasert, Patompong; Stokes, Michael B.; Knight, Eric L. (2014). "Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies". American Journal of Nephrology. 40 (1): 29–35. doi:10.1159/000364782. ISSN 1421-9670.
  23. Richardson GE, Johnson BE (1992). "Paraneoplastic syndromes in lung cancer". Curr Opin Oncol. 4 (2): 323–33. PMID 1591305.
  24. Gold PJ, Fefer A, Thompson JA (1996). "Paraneoplastic manifestations of renal cell carcinoma". Semin Urol Oncol. 14 (4): 216–22. PMID 8946620.
  25. Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS (2009). "Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy". JOP. 10 (1): 37–42. PMID 19129613.
  26. Pelosof LC, Gerber DE (2010). "Paraneoplastic syndromes: an approach to diagnosis and treatment". Mayo Clin Proc. 85 (9): 838–54. doi:10.4065/mcp.2010.0099. PMC 2931619. PMID 20810794.
  27. Henry K (July 2019). "Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment". Semin Diagn Pathol. 36 (4): 204–210. doi:10.1053/j.semdp.2019.01.002. PMID 30876820.
  28. NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014
  29. Carter, Brett W.; Glisson, Bonnie S.; Truong, Mylene T.; Erasmus, Jeremy J. (2014). "Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations". RadioGraphics. 34 (6): 1707–1721. doi:10.1148/rg.346140178. ISSN 0271-5333.
  30. Rosado-de-Christenson, M L; Templeton, P A; Moran, C A (1994). "Bronchogenic carcinoma: radiologic-pathologic correlation". RadioGraphics. 14 (2): 429–446. doi:10.1148/radiographics.14.2.8190965. ISSN 0271-5333.
  31. Reynolds, Arich R.; Furlan, Alessandro; Fetzer, David T.; Sasatomi, Eizaburo; Borhani, Amir A.; Heller, Matthew T.; Tublin, Mitchell E. (2015). "Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know". RadioGraphics. 35 (2): 371–386. doi:10.1148/rg.352140114. ISSN 0271-5333.
  32. Flores, Yvonne N.; Lang, Cathy M.; Salmerón, Jorge; Bastani, Roshan (2011). "Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico". Journal of Community Health. 37 (2): 403–411. doi:10.1007/s10900-011-9457-4. ISSN 0094-5145.
  33. Mišković, Josip (2016). "DIAGNOSTIC VALUE OF FINE NEEDLE ASPIRATION CYTOLOGY FOR BREAST TUMORS". ACTA CLINICA CROATICA: 625–628. doi:10.20471/acc.2016.55.04.13. ISSN 0353-9466.
  34. Mišković J, Zorić A, Radić Mišković H, Šoljić V (2016). "Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors". Acta Clin Croat. 55 (4): 625–628. doi:10.20471/acc.2016.55.04.13. PMID 29117654.
  35. McKenna RJ (1994). "The abnormal mammogram radiographic findings, diagnostic options, pathology, and stage of cancer diagnosis". Cancer. 74 (1 Suppl): 244–55. doi:10.1002/cncr.2820741308. PMID 8004594.
  36. Cairns, Paul; Srivastava, Sudhir; Grizzle, William E. (2011). "Renal cell carcinoma". Cancer Biomarkers. 9 (1–6): 461–473. doi:10.3233/CBM-2011-0176. ISSN 1875-8592.
  37. de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR; et al. (1995). "Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo". J Clin Invest. 95 (6): 2846–52. doi:10.1172/JCI117990. PMC 295971. PMID 7769125.
  38. Laski ME, Vugrin D (1987). "Paraneoplastic syndromes in hypernephroma". Semin Nephrol. 7 (2): 123–30. PMID 3306861.
  39. Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N (2010). "Imaging renal cell carcinoma with ultrasonography, CT and MRI". Nat Rev Urol. 7 (6): 311–25. doi:10.1038/nrurol.2010.63. PMID 20479778.
  40. Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS (2009). "Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy". JOP. 10 (1): 37–42. PMID 19129613.
  41. Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A; et al. (2005). "Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage". Clin Transl Oncol. 7 (5): 189–97. PMID 15960930.
  42. Holly, Elizabeth A.; Chaliha, Indranushi; Bracci, Paige M.; Gautam, Manjushree (2004). "Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area". Clinical Gastroenterology and Hepatology. 2 (6): 510–517. doi:10.1016/S1542-3565(04)00171-5. ISSN 1542-3565.
  43. Schmidt-Hansen M, Berendse S, Hamilton W (2016). "Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review". Pancreas. 45 (6): 814–8. doi:10.1097/MPA.0000000000000527. PMID 26495795.
  44. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C; et al. (2013). "Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines". J Natl Compr Canc Netw. 11 (5): 531–46. PMID 23667204.
  45. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R (1993). "Cancer of the stomach. A patient care study by the American College of Surgeons". Ann Surg. 218 (5): 583–92. doi:10.1097/00000658-199321850-00002. PMC 1243028. PMID 8239772.
  46. Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM; et al. (1988). "Gastric adenocarcinoma: CT versus surgical staging". Radiology. 167 (2): 335–40. doi:10.1148/radiology.167.2.3357941. PMID 3357941.
  47. Karita M, Tada M (1994). "Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy". Gastrointest Endosc. 40 (6): 749–53. PMID 7859977.
  48. Hagler KT, Lynch JW (2004). "Paraneoplastic manifestations of lymphoma". Clin Lymphoma. 5 (1): 29–36. PMID 15245605.
  49. Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC; et al. (2011). "Spectrum of paraneoplastic disease associated with lymphoma". Neurology. 76 (8): 705–10. doi:10.1212/WNL.0b013e31820d62eb. PMID 21339498.
  50. Hippisley-Cox J, Coupland C (2011). "Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm". BMJ. 344: d8009. doi:10.1136/bmj.d8009. PMC 3251328. PMID 22217630.
  51. Li J, Fadare O, Xiang L, Kong B, Zheng W (2012). "Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis". J Hematol Oncol. 5: 8. doi:10.1186/1756-8722-5-8. PMC 3328281. PMID 22405464.